Publications: Difference between revisions

From Alfaar Research
Jump to navigation Jump to search
No edit summary
No edit summary
 
(2 intermediate revisions by the same user not shown)
Line 9: Line 9:
!IF
!IF
!Rank
!Rank
!Theme
!Submitted
!Submitted
!Accepted
!Accepted
Line 20: Line 21:
|5.033
|5.033
|Q1
|Q1
|Education
|August 31, 2011
|August 31, 2011
|November 29, 2011
|November 29, 2011
Line 31: Line 33:
| -
| -
| -
| -
|Pediatric Cances
|
|
|
|
Line 42: Line 45:
| -
| -
| -
| -
|Biology
|
|
|
|
Line 53: Line 57:
|1.771
|1.771
|Q3
|Q3
|Education
|
|
|
|
Line 64: Line 69:
| -
| -
| -
| -
|Clinical Research
|
|
|
|
Line 75: Line 81:
|2.890
|2.890
|Q3
|Q3
|Ocular oncology
|
|
|
|
Line 86: Line 93:
|1.412
|1.412
|Q4
|Q4
|Ocular oncology
|
|
|
|
Line 97: Line 105:
| -
| -
| -
| -
|Pediatric Oncology
|
|
|
|
Line 108: Line 117:
|1.170
|1.170
|Q4
|Q4
|Ocular oncology
|
|
|
|
Line 119: Line 129:
| -
| -
| -
| -
|Pediatric Oncology
|
|
|
|
Line 130: Line 141:
| -
| -
| -
| -
|Clinical Researrch
|
|
|
|
Line 141: Line 153:
| -
| -
| -
| -
|Ocular oncology
|
|
|
|
Line 152: Line 165:
| -
| -
| -
| -
|Ocular oncology
|
|
|
|
Line 163: Line 177:
|1.170
|1.170
|Q4
|Q4
|Pediatric Oncology
|
|
|
|
Line 174: Line 189:
|2.256
|2.256
|Q3
|Q3
|Pediatric Oncology
|
|
|
|
Line 185: Line 201:
|1.771
|1.771
|Q3
|Q3
|Education
|
|
|
|
Line 196: Line 213:
|2.029
|2.029
|Q3
|Q3
|Ocular oncology
|
|
|
|
Line 207: Line 225:
|1.274
|1.274
|Q4
|Q4
|Ocular oncology
|
|
|
|
Line 218: Line 237:
|1.274
|1.274
|Q4
|Q4
|Ocular oncology
|
|
|
|
Line 229: Line 249:
|4.711
|4.711
|Q2
|Q2
|Pediatric Oncology
|
|
|
|
Line 240: Line 261:
|1.170
|1.170
|Q4
|Q4
|Pediatric Oncology
|
|
|
|
Line 251: Line 273:
|3.850
|3.850
|Q3
|Q3
|Pediatric Oncology
|
|
|
|
Line 262: Line 285:
|3.221
|3.221
|Q3
|Q3
|Oncology
|
|
|
|
Line 273: Line 297:
|2.590
|2.590
|Q4
|Q4
|Oncology
|
|
|
|
Line 284: Line 309:
|1.532
|1.532
|Q4
|Q4
|Pediatric Oncology
|
|
|
|
Line 295: Line 321:
|6.921
|6.921
|Q1
|Q1
|Oncology
|
|
|
|
Line 306: Line 333:
|4.996
|4.996
|Q2
|Q2
|Biology
|
|
|
|
Line 317: Line 345:
|5.834
|5.834
|Q1
|Q1
|Biology
|
|
|
|
Line 328: Line 357:
|2.070
|2.070
|Q3
|Q3
|Pediatric Oncology
|
|
|
|
Line 339: Line 369:
|3.535
|3.535
|Q2
|Q2
|Ocular oncology
|
|
|
|
Line 350: Line 381:
|13.353
|13.353
|Q1
|Q1
|Oncology
|
|
|
|
Line 361: Line 393:
|4.456
|4.456
|Q1
|Q1
|Ocular oncology
|
|
|
|
Line 372: Line 405:
|6.883
|6.883
|Q1
|Q1
|Ocular oncology
|
|
|
|
Line 383: Line 417:
|3.535
|3.535
|Q2
|Q2
|Ocular oncology
|
|
|
|
Line 394: Line 429:
|38.927
|38.927
|Q1
|Q1
|Ophthalmology
|
|
|
|
Line 405: Line 441:
|38.927
|38.927
|Q1
|Q1
|Ophthalmology
|
|
|
|
Line 416: Line 453:
|1.397
|1.397
|Q4
|Q4
|Pediatric Oncology
|
|
|
|
Line 427: Line 465:
|3.535
|3.535
|Q2
|Q2
|Ocular oncology
|
|
|
|
Line 439: Line 478:
|9.587
|9.587
|Q1
|Q1
|Biology
|
|
|
|
Line 450: Line 490:
|7.590
|7.590
|Q1
|Q1
|Ocular oncology
|
|
|
|
Line 461: Line 502:
|1.922
|1.922
|Q4
|Q4
|Ocular oncology
|
|
|
|
|-
|-
|'''Abdelazeem''' B, Abbas KS, Shehata J, El-Shahat NA, Eltaras MM, Qaddoumi I, Alfaar AS.
|Abdelazeem B, Abbas KS, Shehata J, El-Shahat NA, Eltaras MM, Qaddoumi I, '''Alfaar''' AS.
|Survival trends for patients with retinoblastoma between 2000 and 2018: What has changed?
|Survival trends for patients with retinoblastoma between 2000 and 2018: What has changed?
|Cancer Med
|Cancer Med
Line 472: Line 514:
|4.711
|4.711
|Q2
|Q2
|Ocular oncology
|
|
|
|
|}
|}

Latest revision as of 10:38, 10 February 2023

Authors Title Journal Online Volume, Issue, Pages DOI IF Rank Theme Submitted Accepted
Alfaar, A. S., Kamal, S., Abouelnaga, S., Greene, W. L., Quintana, Y., Ribeiro, R. C., & Qaddoumi, I. A. International telepharmacy education: another venue to improve cancer care in the developing world. Telemedicine Journal and E-Health : The Official Journal of the American Telemedicine Association, 2012 18(6), 470–474. https://doi.org/10.1089/tmj.2011.0182 5.033 Q1 Education August 31, 2011 November 29, 2011
Meselhy, G. T., Sallam, K. R., Elshafiey, M. M., Refaat, A., Samir, A., & Younes, A. A. Sonographic guidance for tunneled central venous catheters insertion in pediatric oncologic patients: guided punctures and guide wire localization. The Chinese-German Journal of Clinical Oncology 2012 11(8), 484–490 https://doi.org/10.1007/s10330-012-1011-z - - Pediatric Cances
Shohdy, K. S., & Alfaar, A. S. Nanoparticles targeting mechanisms in cancer therapy: current limitations and emerging solutions. Therapeutic Delivery 2013 4(9), 1197–1209 https://doi.org/10.4155/tde.13.75 - - Biology
Amgad, M., & AlFaar, A. S. Integrating web 2.0 in clinical research education in a developing country. Journal of Cancer Education : The Official Journal of the American Association for Cancer Education 2014 29(3), 536–540 https://doi.org/10.1007/s13187-013-0595-5 1.771 Q3 Education
Alfaar, A., & Nour, R. What a reference manager can add for a physician in web 2.0 era. The Egyptian Journal of Cardiothoracic Anesthesia, 2014 8(2), 55 https://doi.org/10.4103/1687-9090.143253 - - Clinical Research
Hassan, W. M., Alfaar, A. S., Bakry, M. S., & Ezzat, S. Orbital tumors in USA: Difference in survival patterns. Cancer Epidemiology 2014 38(5), 515–522 https://doi.org/10.1016/j.canep.2014.07.001 2.890 Q3 Ocular oncology
Taha, H., Amer, H. Z., El-Zomor, H., Alieldin, A., Nour, R., Konsowa, R., Zekri, W., el Nadi, E., & Alfaar, A. S. Phthisis Bulbi: Clinical and Pathologic Findings in Retinoblastoma. Fetal and Pediatric Pathology 2015 34(3), 176–184. https://doi.org/10.3109/15513815.2015.1014951 1.412 Q4 Ocular oncology
Zekri, W., Yehia, D., Elshafie, M. M., Zaghloul, M. S., El-Kinaai, N., Taha, H., Refaat, A., Younes, A. A., & Alfaar, A. S. Bilateral clear cell sarcoma of the kidney. Journal of the Egyptian National Cancer Institute, 2015 27(2), 97–100. https://doi.org/10.1016/j.jnci.2015.03.002 - - Pediatric Oncology
Alfaar, A. S., Zamzam, M., Abdalla, B., Magdi, R., & El-Kinaai, N. Childhood Ewing Sarcoma of the Orbit. Journal of Pediatric Hematology/Oncology 2015 37(6), 433–437 https://doi.org/10.1097/MPH.0000000000000346 1.170 Q4 Ocular oncology
Zekri, W., Yehia, D., Elshafie, M. M., Zaghloul, M. S., El-Kinaai, N., Taha, H., Refaat, A., Younes, A. A., & Alfaar, A. S. Bilateral clear cell sarcoma of the kidney. Journal of the Egyptian National Cancer Institute, 2015 27(2), 97–100. https://doi.org/10.1016/j.jnci.2015.03.002 - - Pediatric Oncology
Hassan, W. M., Mehanna, M., Nour, R., Yehia, D., Atta, N., & Alfaar, A. S. Association between quality of clinical trials and human development index in heart failure using JADAD scale. Principles and Practice of Clinical Research 2015 1(2), 40–46 https://journal.ppcr.org/index.php/ppcrjournal/article/view/9 - - Clinical Researrch
El-Nadi, E., Elzomor, H., Labib, R. M., Alfaar, A. S., Zaghloul, M. S., Taha, H., & Elwakeel, M. Childhood orbital rhabdomyosarcoma: Report from Children’s Cancer Hospital-57357-Egypt. Journal of Solid Tumors 2015 2(5), 94 https://www.sciedupress.com/journal/index.php/jst/article/view/6603 - - Ocular oncology
El Zomor, H., Nour, R., Alieldin, A., Taha, H., Montasr, M. M., Moussa, E., el Nadi, E., Ezzat, S., & Alfaar, A. S. Clinical presentation of intraocular retinoblastoma; 5-year hospital-based registry in Egypt. Journal of the Egyptian National Cancer Institute 2015 27(4), 195–203 https://doi.org/10.1016/j.jnci.2015.09.002 - - Ocular oncology
Alfaar, A. S., Zamzam, M., Abdalla, B., Magdi, R., & El-Kinaai, N. Childhood Ewing Sarcoma of Orbit: Is it So Fatal? Journal of Pediatric Hematology/Oncology 2016 38(6), 493 https://doi.org/10.1097/MPH.0000000000000600 1.170 Q4 Pediatric Oncology
Labib, R. M., Mostafa, M. M., Alfaar, A. S., Yehia, D., Alaa, M., Elzayat, M. G., Adel, M., Ezzat, S., & Abo El-Naga, S. Biorepository for Pediatric Cancer with Minimal Resources: Meeting the Challenges. Biopreservation and Biobanking, 2016 14(1), 9–16 https://doi.org/10.1089/bio.2015.0004 2.256 Q3 Pediatric Oncology
Alfaar, A. S., Hassan, W. M., Bakry, M. S., & Ezzat, S. Clinical Research Recession: Training Needs Perception Among Medical Students. Journal of Cancer Education : The Official Journal of the American Association for Cancer Education, 2017 32(4), 728–733. https://doi.org/10.1007/s13187-016-0995-4 1.771 Q3 Education
Alfaar, A. S., Nour, R., Bakry, M. S., Kamal, M., Hassanain, O., Labib, R. M., Rashed, W. M., Elzomor, H., Alieldin, A., Taha, H., Zaghloul, M. S., Ezzat, S., & AboElnaga, S. A change roadmap towards research paradigm in low-resource countries: retinoblastoma model in Egypt. International Ophthalmology 2017 37(1), 111–118. https://doi.org/10.1007/s10792-016-0233-4 2.029 Q3 Ocular oncology
ElZomor H, Taha H, Aleieldin A, Nour R, Zaghloul MS, Fawzi M, Kamel A, Alfaar AS. High Risk Retinoblastoma: Prevalence and Success of Treatment in Developing Countries. Ophthalmic Genetics, 2015 36(3):287-9 https://10.3109/13816810.2015.1016241 1.274 Q4 Ocular oncology
Elzomor, H., Taha, H., Nour, R., Aleieldin, A., Zaghloul, M. S., Qaddoumi, I., & Alfaar, A. S. A multidisciplinary approach to improving the care and outcomes of patients with retinoblastoma at a pediatric cancer hospital in Egypt. Ophthalmic Genetics, 2017 38(4), 345–351. https://doi.org/10.1080/13816810.2016.1227995 1.274 Q4 Ocular oncology
Alfaar, A. S., Hassan, W. M., Bakry, M. S., & Qaddoumi, I. Neonates with cancer and causes of death; lessons from 615 cases in the SEER databases. Cancer Medicine, 2017 6(7), 1817–1826. https://doi.org/10.1002/cam4.1122 4.711 Q2 Pediatric Oncology
Rashed, W. M., Zekri, W., Awad, M., Taha, H., Abdalla, B., & Alfaar, A. S. Nonfunctioning Adrenocortical Carcinoma in Pediatric Acute Lymphoblastic Leukemia: A Case Report of a Rare Multiple Primaries Combination. Journal of Pediatric Hematology/Oncology, 2017 39(2), 150–152. https://doi.org/10.1097/MPH.0000000000000699 1.170 Q4 Pediatric Oncology
Adly, M. H., Sobhy, M., Rezk, M. A., Ishak, M., Afifi, M. A., Shafie, A. el, Ali, M. A., Zekri, W., Alfaar, A. S., & Rashed, W. M. Risk of second malignancies among survivors of pediatric thyroid cancer. International Journal of Clinical Oncology, 2018 23(4), 625–633. https://doi.org/10.1007/s10147-018-1256-9 3.850 Q3 Pediatric Oncology
Rashed, W. M., Saad, A. M., Al-Husseini, M. J., Galal, A. M., Ismael, A. M., Al-Tayep, A. M., el Shafie, A., Ali, M. A., & Alfaar, A. S. Incidence of adrenal gland tumor as a second primary malignancy: SEER-based study. Endocrine Connections 2018 7(10), 1040–1048. https://doi.org/10.1530/EC-18-0304 3.221 Q3 Oncology
Al-Husseini, M. J., Saad, A. M., El-Shewy, K. M., Nissan, N. E., Gad, M. M., Alzuabi, M. A., & Samir Alfaar, A. Prior malignancy impact on survival outcomes of glioblastoma multiforme; population-based study. International Journal of Neuroscience 2018 129(5), 447-454 https://doi.org/10.1080/00207454.2018.1538989 2.590 Q4 Oncology
Chamdine, O., Elhawary, G. A. S., Alfaar, A. S., & Qaddoumi, I. The incidence of brainstem primitive neuroectodermal tumors of childhood based on SEER data. Child’s Nervous System : ChNS : Official Journal of the International Society for Pediatric Neurosurgery 2018 34(3), 431–439 https://doi.org/10.1007/s00381-017-3687-4 1.532 Q4 Pediatric Oncology
Saad, A. M., Gad, M. M., Al-Husseini, M. J., AlKhayat, M. A., Rachid, A., Alfaar, A. S., & Hamoda, H. M. Suicidal death within a year of a cancer diagnosis: A population-based study. Cancer 2019 125(6), 972–979 https://doi.org/10.1002/cncr.31876 6.921 Q1 Oncology
Reichhart, N., Schöberl, S., Keckeis, S., Alfaar, A. S., Roubeix, C., Cordes, M., Crespo-Garcia, S., Haeckel, A., Kociok, N., Föckler, R., Fels, G., Mataruga, A., Rauh, R., Milenkovic, V. M., Zühlke, K., Klussmann, E., Schellenberger, E., & Strauß, O. Anoctamin-4 is a bona fide Ca2+-dependent non-selective cation channel. Scientific Reports, 2019 9(1), 2257 https://doi.org/10.1038/s41598-018-37287-y 4.996 Q2 Biology
Cordes, M., Bucichowski, P., Alfaar, A. S., Tsang, S. H., Almedawar, S., Reichhart, N., & Strauß, O. Inhibition of Ca2+ channel surface expression by mutant bestrophin-1 in RPE cells. FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology 2020 May 2019, fj.201901202RR https://doi.org/10.1096/fj.201901202RR 5.834 Q1 Biology
Zekri, W., Hammad, M., Rashed, W. M., Ahmed, G., Elshafie, M., Adly, M. H., Elborai, Y., Abdalla, B., Taha, H., Elkinaae, N., Refaat, A., Younes, A., Alfaar, A. S., Younis, A., & Alfaar, A. S. The outcome of childhood adrenocortical carcinoma in Egypt: A model from developing countries. Pediatric Hematology and Oncology 2020 198-210 https://doi.org/10.1080/08880018.2019.1710309 2.070 Q3 Pediatric Oncology
Alfaar, A. S., Saad, A. M., KhalafAllah, M. T., Elsherif, O. E., Osman, M. H., & Strauß, O. Second primary malignancies of eye and ocular adnexa after a first primary elsewhere in the body. Graefe’s Archive for Clinical and Experimental Ophthalmology = Albrecht von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie 2020 259, 515–526 https://doi.org/10.1007/s00417-020-04896-1 3.535 Q2 Ocular oncology
Saad, A. M., Elmatboly, A. M., Gad, M. M., Al-Husseini, M. J., Jazieh, K. A., Alzuabi, M. A., & Alfaar, A. S. Association of Brain Cancer With Risk of Suicide. JAMA Network Open 2020 3(5), e203862 https://doi.org/10.1001/jamanetworkopen.2020.3862 13.353 Q1 Oncology
El Zomor, H., Nour, R., Saad, A., Taha, H., Shelil, A. E., Aleieldin, A., Saad Zaghloul, M., & Alfaar, A. S. Unilateral retinoblastoma; natural history and an age-based protocol in 248 patients. Eye. 2020 35(9):2564-2572 https://doi.org/10.1038/s41433-020-01275-2 4.456 Q1 Ocular oncology
Alfaar, A. S., Saad, A., Elzouki, S., Abdel-Rahman, M. H., Strauss, O., & Rehak, M. Uveal melanoma-associated cancers revisited. ESMO Open 2020 5(6), e000990. https://doi.org/10.1136/esmoopen-2020-000990 6.883 Q1 Ocular oncology
Alfaar, A. S., Saad, A. M., KhalafAllah, M. T., Elsherif, O. E., Osman, M. H., & Strauß, O. Second primary malignancies of eye and ocular adnexa after a first primary elsewhere in the body. Graefe’s Archive for Clinical and Experimental Ophthalmology. 2020 https://doi.org/10.1007/s00417-020-04896-1 3.535 Q2 Ocular oncology
Bourne, R., Steinmetz, J. D., Flaxman, S., Briant, P. S., Taylor, H. R., Resnikoff, S., Casson, R. J., Abdoli, A., Abu-Gharbieh, E., Afshin, A., Ahmadieh, H., Akalu, Y., Alamneh, A. A., Alemayehu, W., Alfaar, A. S., Alipour, V., Anbesu, E. W., Androudi, S., Arabloo, J., … Vos, T. Trends in prevalence of blindness and distance and near vision impairment over 30 years: an analysis for the Global Burden of Disease Study. The Lancet Global Health 2020 20, 1–14 https://doi.org/10.1016/S2214-109X(20)30425-3 38.927 Q1 Ophthalmology
Adelson, J. D., Bourne, R. R. A., Briant, P. S., Flaxman, S. R., Taylor, H. R. B., Jonas, J. B., Abdoli, A. A., Abrha, W. A., Abualhasan, A., Abu-Gharbieh, E. G., Adal, T. G., Afshin, A., Ahmadieh, H., Alemayehu, W., Alemzadeh, S. A. S., Alfaar, A. S., Alipour, V., Androudi, S., Arabloo, J., … Vos, T. Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study. The Lancet Global Health 2020 20 https://doi.org/10.1016/S2214-109X(20)30489-7 38.927 Q1 Ophthalmology
Hammad, M., Hosny, M., Khalil, E., Alfaar, A., & Fawzy, M. Pediatric ependymoma: A single-center experience from a developing country. Indian Journal of Cancer 2020 55(1), 382–389 https://doi.org/10.4103/ijc.IJC_373_19 1.397 Q4 Pediatric Oncology
Alfaar, A. S., Saad, A., Wiedemann, P., & Rehak, M. The epidemiology of uveal melanoma in Germany: a nationwide report of incidence and survival between 2009 and 2015. Graefe’s Archive for Clinical and Experimental Ophthalmology = Albrecht von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie 2021 260, pages1723–1731 https://doi.org/10.1007/s00417-021-05317-7 3.535 Q2 Ocular oncology
Alfaar AS, Stürzbecher L, Diedrichs-Möhring M, Lam M, Roubeix C, Ritter J, Schumann K, Annamalai B, Pompös IM, Rohrer B, Sennlaub F, Reichhart N, Wildner G, Strauß O. FoxP3 expression by retinal pigment epithelial cells: transcription factor with potential relevance for the pathology of age-related macular degeneration J Neuroinflammation

.

2022 19(1):260 https://doi.org/10.1186/s12974-022-02620-w 9.587 Q1 Biology
Abdelazeem B, Abbas KS, Shehata J, Alfaar AS. Increased Risk of Subsequent Skin Melanoma in Patients with Retinoblastoma: SEER-Based Results. J Invest Dermatol. 2022 142(11):3123-3125 https://doi.org/10.1016/j.jid.2022.04.013 7.590 Q1 Ocular oncology
Alfaar AS, Suckert CN, Rehak M, Girbardt C. The epidemiology of adults' eyelid malignancies in Germany between 2009 and 2015; An analysis of 42,710 patients' data. Eur J Ophthalmol 2022 https://doi.org/10.1177/11206721221125018 1.922 Q4 Ocular oncology
Abdelazeem B, Abbas KS, Shehata J, El-Shahat NA, Eltaras MM, Qaddoumi I, Alfaar AS. Survival trends for patients with retinoblastoma between 2000 and 2018: What has changed? Cancer Med 2022 https://doi.org/10.1002/cam4.5406 4.711 Q2 Ocular oncology